News

The test will measure the levels of an anti-cancer drug, 5-fluorouracil (5-FU), in the blood of cancer patients and allows oncologists to determine the optimal dose of 5-FU

The investment will increase the production of GIBCO cell culture products and secures the supply chain for Europe, Americas and Asia, the company said. Life Technologies chairman and

The company in collaboration with the University of Washington’s School of Public Health evaluated the levels of porphyrins in the urine of ASD children to determine if certain

The FDA conducted analytical tests of X-ROCK for men, which showed that products contained sildenafil and hydroxythiohomosildenafil. Hydroxythiohomosildenafil is an analogue sildenafil and is expected to possess a

The curated genomic, molecular and clinical profiles from individual patients are added to the platform’s existing repository of data from animal and cell line models. NextBio president and

The primary endpoint of efficacy has met non-inferiority to sevelamer hydrochloride in the top-line results, which evaluated the change of serum phosphorus from baseline. JT and Torii are

Under the research collaboration, serum and urine samples collected by Hirosaki investigators from well-characterized patient and control populations in Japan, will be examined. The glycan analysis will be

The company expects to maintain sufficient reserves of oncology drug supplies and multiple manufacturing facilities approved by the FDA. Spectrum president and chief executive officer Rajesh Shrotriya said

Xarelto (rivaroxaban tablet) is indicated for the prevention of stroke and systemic embolism in patients with AF, in whom anticoagulation is appropriate. Bayer Corporate Affairs head Doug Grant